This locus harbors multiple coronary artery disease (CAD) risk variants, including two functional variants reported to abrogate the function of an enhancer (ECAD9) by disrupting TEAD3 and STAT1 binding, thereby misregulating the expression of the target genes, CDKN2A/B (22, –24). Here, CDKN2A is linked to coronary artery disorder.